|
|
Les lésions histologiques associées à l’infection par le SARS-CoV-2
Paul Hofman
,
Marie-Christine Copin
,
Arnault Tauziede-Espariat
,
Homa Adle-Biassette
,
Francesco Fortarezza
,
et al.
Journal articles
inserm-03549813v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Invasive dedifferentiated melanoma cells inhibit JAK1-STAT3-driven actomyosin contractility of human fibroblastic reticular cells of the lymph node
Christopher Rovera
,
Ilona Berestjuk
,
Margaux Lecacheur
,
Serena Diazzi
,
Aude Mallavialle
,
et al.
2021
Preprints, Working Papers, ...
hal-03417408v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Editorial: Immunology of Vitiligo
Julien Seneschal
,
John E Harris
,
I Caroline Le Poole
,
Thierry Passeron
,
Reinhart Speeckaert
,
et al.
Journal articles
hal-03436980v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Compounds Triggering ER Stress Exert Anti-Melanoma Effects and Overcome BRAF Inhibitor Resistance
Michaël Cerezo
,
Abdelali Lehraiki
,
Antoine Millet
,
Florian Rouaud
,
Magali Plaisant
,
et al.
Journal articles
hal-01357448v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
GAPDH Overexpression in the T Cell Lineage Promotes Angioimmunoblastic T Cell Lymphoma through an NF-κB-Dependent Mechanism
Laura Mondragón
,
Rana Mhaidly
,
Gian Marco de Donatis
,
Marie Tosolini
,
Pascal Dao
,
et al.
Journal articles
hal-02323021v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Efficacy and Safety of Tacrolimus 0.1% for the Treatment of Facial Vitiligo: A Multicenter Randomized, Double-Blinded, Vehicle-Controlled Study
Julien Seneschal
,
Alexandra Duplaine
,
Hervé Maillard
,
Thierry Passeron
,
Nicolas Andreu
,
et al.
Journal articles
hal-03700544v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Targeting Discoidin Domain Receptors DDR1 and DDR2 overcomes matrix‐mediated tumor cell adaptation and tolerance to BRAF‐targeted therapy in melanoma
Ilona Berestjuk
,
Margaux Lecacheur
,
Alexandrine Carminati
,
Serena Diazzi
,
Christopher Rovera
,
et al.
Journal articles
hal-03533365v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
E2F1 inhibition mediates cell death of metastatic melanoma
Florian Rouaud
,
Nedra Hamouda-Tekaya
,
Michaël Cerezo
,
Patricia Abbe
,
Joséphine Zangari
,
et al.
Journal articles
inserm-02529927v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicity
Yann Cheli
,
Meri Tulic
,
Najla El Hachem
,
Nicolas Nottet
,
Arnaud Jacquel
,
et al.
Journal articles
inserm-03138806v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Ingenol mebutate to treat lentigo maligna of the head (face and scalp): A prospective, multicenter, single-arm phase 2 trial indicates no benefit
Henri Montaudié
,
Florence Le Duff
,
Catherine Butori
,
Véronique Hofman
,
Eric Fontas
,
et al.
Journal articles
hal-03489705v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Discovery of a new molecule inducing melanoma cell death: dual AMPK/MELK targeting for novel melanoma therapies
Emilie Jaune
,
Elisa Cavazza
,
Cyril Ronco
,
Oleksandr Grytsai
,
Patricia Abbe
,
et al.
Journal articles
hal-03437110v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Laser treatment of epidermal nevi: A multicenter retrospective study with long-term follow-up
Azzam Alkhalifah
,
Frederike Fransen
,
Florence Le Duff
,
Jean-Philippe Lacour
,
Albert Wolkerstorfer
,
et al.
Journal articles
hal-03492632v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Apremilast in Combination with Narrowband UVB in the Treatment of Vitiligo: A 52-Week Monocentric Prospective Randomized Placebo-Controlled Study
Abdallah Khemis
,
Eric Fontas
,
Sophie Moulin
,
Henri Montaudié
,
Jean-Philippe Lacour
,
et al.
Journal articles
hal-03492443v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|